Thalidomide: An overview of its pharmacological mechanisms of action

Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry

Volumn 5, Issue 1, 2006, Pages 71-77

  Sampaio, Elizabeth P ^b   Carvalho, Daniel S ^b   Nery, José Augusto C ^b   Lopes, Ulisses G ^a   Sarno, Euzenir N ^b  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Angiogenesis; Cyclooxigenase 2; CYP2C19; Immunomodulatory; Inflammatory disorders; Untreated reactional patients (ENL)

Indexed keywords

ACTIVATED CARBON; ADALIMUMAB; CISPLATIN; CLOFAZIMINE; CORTICOSTEROID; CYCLOOXYGENASE 2; CYCLOPHOSPHAMIDE; CYTOCHROME P450 2C19; DEXAMETHASONE; DOXORUBICIN; ETANERCEPT; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLIXIMAB; INTERLEUKIN 12; INTERLEUKIN 6; INTERLEUKIN 8; ORAL CONTRACEPTIVE AGENT; PACLITAXEL; PENTOXIFYLLINE; PLACEBO; PREDNISONE; THALIDOMID; THALIDOMIDE; THALIDOMIDE DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; UNINDEXED DRUG; VASCULOTROPIN; VINCRISTINE; ZOLEDRONIC ACID;

AREA UNDER THE CURVE; AUTONOMIC NEUROPATHY; BODY TEMPERATURE DISORDER; CARDIOVASCULAR DISEASE; CHRONIC INFLAMMATION; CLINICAL FEATURE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONSTIPATION; CROHN DISEASE; DEMYELINATING DISEASE; DOSE RESPONSE; DROWSINESS; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG HYPERSENSITIVITY; DRUG INDICATION; DRUG INTOXICATION; DRUG MECHANISM; DRUG MEGADOSE; DRUG METABOLISM; DRUG SAFETY; DRUG TARGETING; ENDOCRINE DISEASE; ENTERITIS; ERYTHEMA NODOSUM LEPROSUM; FATIGUE; FOOD DRUG INTERACTION; GASTROINTESTINAL TOXICITY; GRAFT VERSUS HOST REACTION; HUMAN; HYPERALGESIA; HYPERESTHESIA; HYPESTHESIA; IMMUNOREGULATION; LOW DRUG DOSE; LYMPHOMA; MONOTHERAPY; MULTIPLE MYELOMA; MUSCLE WEAKNESS; NEUROPATHY; NEUROTOXICITY; NONHUMAN; PARESTHESIA; PATHOGENESIS; PERIPHERAL NEUROPATHY; POLYNEUROPATHY; PROTEIN FUNCTION; PROTEIN SYNTHESIS; PYRAMIDAL SIGN; REVIEW; SEDATION; SENSORY DYSFUNCTION; SIDE EFFECT; SINGLE DRUG DOSE; SKIN TOXICITY; SYSTEMIC LUPUS ERYTHEMATOSUS; TERATOGENICITY; TUBERCULOSIS;

EID: 33744474301     PISSN: 18715230     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152306775537337     Document Type: Review

References (55)

1. Franks, M.E.; MacPherson, G.R.; Figg, W.D. Lancet, 2004, 363, 1802.
2. Faver, I.R.; Guerra, S.G.; Su, W.P.; el-Azhary, R. Int. J. Dermatol., 2005, 44, 61.
3. Lipson, A.H. Teratology, 1992, 46, 411.
4. Sheskin, J. Clin. Pharmacol Ther., 1965, 40, 303.
5. Sampaio, E.P.; Sarno, E.N.; Galilly, R.; Cohn, Z.A.; Kaplan, G. J. Exp. Med., 1991, 173 699.
6. D'Amato, R.J.; Loughnan, M.S.; Flynn, E.; Folkman, J. Proc. Natl. Acad. Sci. USA, 1994, 91, 4082.
7. Matthews, S.J.; McCoy, C. Clin. Ther., 2003, 25, 342.
8. Teo, S.K.; Colburn, W.A.; Tracewell, W.G.; Kook, K.A.; Stirling, D.I.; Jaworsky, M.S.; Scheffler, M.A.; Thomas, S.D.; Laskin, O.L. Clin. Pharmacokinet., 2004, 43, 311.
9. Ando, Y.; Fuse, E.; Figg, W.D. Clin. Cancer Res., 2002, 8, 1964.
10. Moreira, A.L.; Sampaio, E.P.; Zmuidzinas, A.; Frindt, P.; Smith, K.A.; Kaplan, G. J. Exp. Med, 1993, 177, 1675.
11. Drosou, A.; Kirsner, R.S.; Welsh, E.; Sullivan, T.P.; Kerdel, F.A. J. Cutan. Med. Surg., 2003, 7, 382.
12. Hochberg, M.C.; Lebwohl, M.G.; Plevy S.E.; Hobbs K.F.; Yocum, D.E. Semin. Arthritis Rheum., 2005, 34, 819.
13. Dimakou, K.; Papaioannides, D.; Latsi, P.; Katsimboula, S.; Korantzopoulos, P.; Orphanidou. In.t J. Clin. Pract., 2004, 58, 1052.
14. Kane, S.; Stone, L.J.; Ehrenpreis, E. J. Clin. Gastroenterol., 2002, 35, 149.
15. Wallis, R.S.; Broder, M.; Wong, J.; Lee, A.; Hoq, L. Clin. Infect. Dis. 2005, 41, S194.
16. Bauer, K.S.; Dixon, S.C.; Figg, W.D. Biochem. Pharmacol., 1998, 55, 1827.
17. Noguchi, T.; Shimazawa, R.; Nagasawa, K.; Hashimoto, Y. Bioorg. Med. Chem. Lett., 2002, 12, 1043.
18. Ladetto, M.; Vallet, S.; Trojan, A.; Dell'aquila, M.; Monitillo, L.; Rosato, R.; Santo, L.; Drandi, D.; Bertola, A.; Falco, P.; Cavallo, F.; Ricca, I.; De, M.F.; Mantoan, B.; Bode-Lesniewska, B.; Pagliano, G.; Francese, R.; Rocci, A.; Astolfi, M.; Compagno, M.; Mariani, S.; Godio, L.; Marino, L.; Ruggeri, M.; Omede, P.; Palumbo, A.; Boccadoro, M. Blood, 2005, 105, 4784.
19. Keifer, J.A.; Guttridge, D.C.; Ashburner, B.P.; Baldwin, A.S.Jr. J. Biol. Chem., 2001, 276, 22382.
20. Hayden, M.S.; Ghosh, S. Genes Dev., 2004, 18, 2195.
21. Lokensgard, J.R.; Hu, S.; van Fenema, E.M.; Sheng, W.S.; Peterson, P.K. J. Infect. Dis., 2000, 182, 983.
22. Moreira, A.L.; Corral, L.G.; Ye, W.; Johnson, B.; Stirling, D.; Muller, G.W.; Freedman, V.H.; Kaplan, G. AIDS Res. Hum. Retroviruses, 1997, 13, 857.
23. Kim, Y.S.; Kim, J.S.; Jung, H.C.; Song, I.S. Mol. Cells, 2004,17, 210.
24. Majumdar, S.; Lamothe, B.; Aggarwal, B.B. J. Immunol., 2002, 168, 2644.
25. Rowland, T.L.; McHugh, S.M.; Deighton, J.; Ewan, P.W.; Dearman, R.J.; Kimber, I. Int. Immunopharmacol., 2001, 1, 49.
26. Yamazaki, S.; Muta, T.; Takeshige, K. J. Biol. Chem., 2001, 276, 27657.
27. Stephens, T.D.; Fillmore, B.J. Teratology, 2000, 61, 189.
28. Chung, F.; Lu, J.; Palmer, B.D.; Kestell, P.; Browett, P.; Baguley, B.C.; Tingle, M.; Ching, L.M. Clin. Cancer Res., 2004, 10, 5949.
29. Haslett, P.A.; Corral, L.G.; Albert, M.; Kaplan, G. J. Exp. Med., 1998, 187, 1885.
30. Gad, S.M.; Shannon, E.J.; Krotoski, W.A.; Hastings, R.C. Lepr. Rev., 1985, 56,35.
31. Bekker, L.G.; Haslett, P.; Maartens G.; Steyn, L.; Kaplan, G. J. Infect. Dis., 2000, 181,954.
32. Verbon, A.; Juffermans, N.P.; Speelman P.; van Deventer, S.J.; ten Berge, I.J.; Guchelaar, H.J.; van der Poll, T. Antimicrob. Agents Chemother., 2000, 44, 2286.
33. Barnhill, R.L.; Doll, N.J.; Millikan, L.E.; Hastings, R.C.; J. Am. Acad. Dermatol., 1984, 11, 814.
34. Gutschow, M.; Hecker, T.;, Thiele, A.; Hauschildt, S.; Eger, K. Bioorg. Med. Chem., 2001, 9, 1059.
35. Shannon, E.J.; Morales, M.J.; Sandoval, F. Immunopharmacology, 1997, 35, 203.
36. Corral, L.G.; Haslett, P.A.; Muller, G.W.; Chen, R.; Wong, L.M.; Ocampo, C.J.; Patterson, R.T.; Stirling, D.I.; Kaplan, G. J. Immunol., 1999, 163, 380.
37. Sampaio, E.P.; Hernandez, M.O.; Carvalho, D.S.; Sarno, E.N. Biomed. Pharmacother., 2002, 56, 13.
38. Wines, N.Y.; Cooper, A.J.; Wines, M.P. Australas. J. Dermatol., 2002, 43, 229.
39. Sarno, E.N.; Sampaio, E.P. Int. J. Lepr. Other Mycobact. Dis., 1996, 64, S69.
40. Sarno, E.N.; Grau, G.E.; Vieira, L.M. and Nery, J.A. Clin. Exp. Immunol., 1991, 84, 103.
41. Sampaio, E.P.; Kaplan, G.; Miranda, A.; Nery, J.A.; Miguel, C.P.; Viana, S.M.; Sarno, E.N. J. Infect. Dis., 1993, 168, 408.
42. Moraes, M.O.; Sarno, E.N.; Teles R.M.; Almeida, A.S.; Saraiva, B.C.; Nery, J.A.; Sampaio, E.P. J. Invest. Dermatol., 2000,115, 935.
43. Sheskin, J. Int. J. Dermatol., 1980, 19, 318.
44. Teo, S.K.; Resztak, K.E.; Scheffler, M.A.; Kook, K.A.; Zeldis, J.B.; Stirling, D.I.; Thomas, S.D. Microbes. Infect., 2002, 4, 1193.
45. Britton, W.J.; Lockwood, D.N. Lancet, 2004, 363, 1209.
46. Sampaio, E.P.; Moraes, M.O.; Nery, J.A.; Santos, A.R.; Matos, H.C.; Sarno, E.N. Clin. Exp. Immunol., 1998, 111, 300.
47. Hayashi, T.; Hideshima, T.; Anderson, K.C. Br. J. Haematol., 2003, 120, 10.
48. Hideshima, T.; Chauhan, D.; Richardson, P.; Mitsiades, C.; Mitsiades, N.; Hayashi, T.; Munshi, N.; Dang, L.; Castro, A.; Palombella, V.; Adams, J.; Anderson, K.C. J. Biol. Chem., 2002, 277, 16639.
49. Weber, D. Cancer Control, 2003, 10, 375.
50. Koc, S.; Leisenring, W.; Flowers, M.E.; Anasetti, C.; Deeg, H.J.; Nash, R.A.; Sanders, J.E.; Witherspoon, R.P.; Appelbaum F.R.; Storb, R.; Martin, P.J. Blood, 2000, 96, 3995.
51. Dimopoulos, M.A.; Eleutherakis-Papaiakovou, V. Am. J. Med., 2004, 117, 508.
52. USP DI VolumeI: Drug Information for the Health Care Professional, Thomson Micromedex: Colorado, 1999.
53. Perri, A.J. 3rd. Hsu, S. Dermatol. Online J., 2003, 9, 5.
54. Radomsky, C.L.; Levine, N. Dermatol. Clin., 2001, 19, 87.
55. Wolkenstein, P.; Latarjet, J.; Roujeau, J.C.; Duguet, C.; Boudeau, S.; Vaillant, L.; Maignan, M.; Schuhmacher, M.H.; Milpied, B.; Pilorget, A.; Bocquet, H.; Brun-Buisson, C.; Revuz, J. Lancet, 1998, 352, 1586.